CAS 1008710-58-4

Formule : C18H14N2O6S

InChI : InChI=1S/C18H14N2O6S/c21-15-14(19-13-7-5-12(6-8-13)17(24)25)27-18(26)20(15)9-10-1-3-11(4-2-10)16(22)23/h1-8,14,19H,9H2,(H,22,23)(H,24,25)

Code InChI : CTJGFHDKWNVPHG-UHFFFAOYSA-N

SMILES : C1=CC(=CC=C1CN2C(=O)C(SC2=O)NC3=CC=C(C=C3)C(=O)O)C(=O)O

4-{[3-(4-Carboxybenzyl)-2,4-dioxo-1,3-thiazolidin-5-yl]amino}benzoic Acid

Produit contrôlé

CAS : 1008710-58-4

Formule : C₁₈H₁₄N₂O₆S

Couleur et forme : Neat

Masse moléculaire : 386.38

Ref: TR-C357340

4-[[5-[(4-Carboxyphenyl)amino]-2,4-dioxo-3-thiazolidinyl]methyl]benzoic acid

CAS : 1008710-58-4

Please enquire for more information about 4-[[5-[(4-Carboxyphenyl)amino]-2,4-dioxo-3-thiazolidinyl]methyl]benzoic acid including the price, delivery time and more detailed product information at the technical inquiry form on this page

Formule : C₁₈₁₄N₂O₆S

Degré de pureté : Min. 95%

Masse moléculaire : 386.38 g/mol

Ref: 3D-FC183981

GI-Y2

CAS : 1008710-58-4

GI-Y2 is a GSDMD inhibitor that suppresses macrophage pyroptosis induced by oxidized low-density lipoprotein (ox-LDL). In vivo, GI-Y2 dose-dependently reduces atherosclerotic plaques and decreases lesion size and fibrosis in the aortic root of ApoE-/- mice. GI-Y2 holds potential for research in pyroptosis and cardiovascular diseases, such as atherosclerosis.

Formule : C₁₈H₁₄N₂O₆S

Couleur et forme : Solid

Masse moléculaire : 386.379

Ref: TM-T206350